Influence of Nociception Level Monitor (NOL) Guided Analgesic Delivery on Robot-assisted Colorectal Surgery
Launched by UNIVERSITY OF SOUTHERN DENMARK · Dec 14, 2022
Trial Information
Current as of July 25, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the use of a device called the Nociception Level Monitor (NOL) to help manage pain during and after robot-assisted colorectal surgery. The goal is to see if using this monitor can improve how much pain medicine is needed, how long patients stay in the hospital after surgery, and how well they recover. The NOL monitor helps doctors understand a patient’s pain levels more accurately, which could lead to better pain management.
To participate in this trial, patients should be between 65 and 74 years old and scheduled for a major robot-assisted colorectal surgery. They should also have a certain level of health as assessed by a scoring system used by anesthesiologists. However, patients who cannot give consent, are pregnant or breastfeeding, or have other specific health conditions are not eligible. If you join the trial, you can expect close monitoring of your pain management during the surgery and support for your recovery process.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • American Society of Anaesthesiologists score III-IV
- • Scheduled for elective major robot-assisted colorectal surgeries
- Exclusion Criteria:
- • Inability to give informed consent
- • planned spinal or epidural anaesthesia
- • all forms of regional anaesthesia, including wound infiltration
- • nonelective procedures
- • pregnancy or lactation
- • atrial fibrillation
About University Of Southern Denmark
The University of Southern Denmark (SDU) is a prominent research institution dedicated to advancing knowledge and innovation across various fields, including health sciences. As a clinical trial sponsor, SDU is committed to conducting rigorous and ethically sound research aimed at improving patient outcomes and informing clinical practices. Leveraging its multidisciplinary expertise and state-of-the-art facilities, SDU collaborates with healthcare professionals, industry partners, and regulatory bodies to develop and execute clinical trials that adhere to the highest standards of scientific integrity and compliance. Through its research initiatives, SDU seeks to contribute to the global body of medical knowledge and enhance the quality of healthcare delivery.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Aabenraa, , Denmark
Patients applied
Trial Officials
Thomas Strøm
Study Director
Hospital of Southern Denmark - Aabenraa
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials